Labormed Divests Portfolio of OTC Products to Recordati

Aug 6, 2012

London, United Kingdom — Plexus Ventures announces the successful completion of a divestment managed on behalf of Labormed, the largest independent pharmaceutical in Romania. The company divested a package of Rx and OTC products to Recordati of Italy.

About Plexus Ventures

Plexus Ventures, founded over 30 years ago, is a leading corporate and business development consultancy for the healthcare industry. Plexus assists clients of all sizes and capabilities to achieve their strategic business development objectives, advising on M&A, asset divestments, licensing and partnership arrangements. Plexus’ industry professionals are conveniently located in the United States, Europe and Asia-Pacific markets, enabling Plexus to benefit its clients with both local knowledge and global reach.

Plexus Ventures Assists First Pharma in Successful Completion of Business Sale to a Strategic Buyer

Apr 17, 2024

Philadelphia, Pennsylvania – First Pharma (“First Pharma”), a private Australian pharmaceutical company operating in the consumer healthcare (“CHC”) segment, has successfully completed the sale of its business to a strategic buyer. First Pharma’s portfolio of products...

Plexus Ventures Assists Sanofi Consumer Health to Divest a Product Portfolio in Australia and South-East Asia to Phoenix Labs

May 5, 2023

Philadelphia, Pennsylvania – Phoenix Labs (“Phoenix”) has acquired a portfolio of well-established consumer health products from Sanofi Consumer Health (“Sanofi”). The portfolio includes Proctosedyl™, the leading pharmacy-only haemorrhoid treatment in Australia and a...

Plexus Ventures Assists Elthera AG in the Licensing of its First-in-Class Antibody

Feb 17, 2023

Philadelphia, Pennsylvania – Plexus Ventures is pleased to announce the successful completion of an out-licensing project conducted on behalf of its client, Elthera AG of Switzerland. Plexus Ventures served as the exclusive business development advisor to Elthera in...

Labormed Divests Portfolio of OTC Products to Recordati

Trending

Plexus Ventures Assists First Pharma in Successful Completion of Business Sale to a Strategic Buyer

Plexus Ventures Assists Sanofi Consumer Health to Divest a Product Portfolio in Australia and South-East Asia to Phoenix Labs

Plexus Ventures Assists Elthera AG in the Licensing of its First-in-Class Antibody